REGENXBIO Inc. financial data

Symbol
RGNX on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 277% % -14%
Debt-to-equity 173% % 154%
Return On Equity -103% % -48%
Return On Assets -38% % 9.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,612,984 shares 3%
Common Stock, Shares, Outstanding 50,892,000 shares 2.7%
Entity Public Float $385,010,782 USD -28%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 51,573,000 shares 4.2%
Weighted Average Number of Shares Outstanding, Diluted 51,573,000 shares 4.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $170,441,000 USD 105%
Research and Development Expense $228,299,000 USD 9.5%
General and Administrative Expense $82,863,000 USD 8.1%
Costs and Expenses $331,639,000 USD 4.7%
Operating Income (Loss) $161,198,000 USD 31%
Nonoperating Income (Expense) $32,680,000 USD -623%
Net Income (Loss) Attributable to Parent $193,878,000 USD 15%
Earnings Per Share, Basic -3.76 USD/shares 18%
Earnings Per Share, Diluted -3.76 USD/shares 18%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $34,466,000 USD -40%
Marketable Securities, Current $195,604,000 USD 10%
Cash, Cash Equivalents, and Short-term Investments $240,900,000 USD -1.6%
Accounts Receivable, after Allowance for Credit Loss, Current $26,379,000 USD 29%
Other Assets, Current $12,905,000 USD -6.3%
Assets, Current $281,281,000 USD 1.2%
Property, Plant and Equipment, Net $104,855,000 USD -11%
Operating Lease, Right-of-Use Asset $47,156,000 USD -12%
Other Assets, Noncurrent $4,613,000 USD 15%
Assets $453,032,000 USD -2.8%
Accounts Payable, Current $21,358,000 USD -6.3%
Employee-related Liabilities, Current $17,418,000 USD -1.1%
Contract with Customer, Liability, Current $10,452,000 USD 8989%
Liabilities, Current $118,095,000 USD 14%
Contract with Customer, Liability, Noncurrent $18,943,000 USD
Operating Lease, Liability, Noncurrent $65,215,000 USD -12%
Other Liabilities, Noncurrent $638,000 USD -82%
Liabilities $350,299,000 USD 70%
Accumulated Other Comprehensive Income (Loss), Net of Tax $687,000 USD 7.3%
Retained Earnings (Accumulated Deficit) $1,126,027,000 USD -21%
Stockholders' Equity Attributable to Parent $102,733,000 USD -60%
Liabilities and Equity $453,032,000 USD -2.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $33,629,000 USD
Net Cash Provided by (Used in) Financing Activities $5,794,000 USD -105%
Net Cash Provided by (Used in) Investing Activities $44,743,000 USD 239%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 50,892,000 shares 2.7%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $72,578,000 USD -7.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $36,496,000 USD -39%
Deferred Tax Assets, Valuation Allowance $374,413,000 USD 11%
Deferred Tax Assets, Gross $407,432,000 USD 8.1%
Operating Lease, Liability $73,501,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $1,024,000 USD 84%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $193,824,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid $97,240,000 USD -12%
Property, Plant and Equipment, Gross $192,047,000 USD 1.1%
Operating Lease, Liability, Current $8,286,000 USD 4.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $10,020,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,237,000 USD -0.88%
Operating Lease, Weighted Average Discount Rate, Percent 0.057 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $23,739,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,943,000 USD -21%
Deferred Tax Assets, Operating Loss Carryforwards $184,528,000 USD 75%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $100,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,051,000 USD 1.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $33,019,000 USD -15%
Share-based Payment Arrangement, Expense $34,563,000 USD -10%
Interest Expense $5,409,000 USD -62%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%